Curative effects of GM1 in the treatment of severe ischemic brain ...
网页GM1 has a good clinical significance in the treatment of patients with severe ischemic brain injury and is worthy of clinical promotion and application. Keywords: monosialotetrahexosyl ganglioside; neuropathy disability score; tumor necrosis factor-α.
Curative effects of GM1 in the treatment of severe ischemic brain ...
网页2018年3月27日 · Over the past few years, it was found that the neuroprotective drug monosialotetrahexosyl ganglioside (GM1) promotes growth and repair the neurological impairment. As reported, the exogenous GM1 has been used to promote the nervous system cell regeneration and synapse formation ( 7 , 8 ).
网页monosialotetrahexosylganglioside GM1 oxaliplatin neurotoxicity. CIPN OIPN. A B S T R A C T. Background: Chronic oxaliplatin-induced peripheral neurotoxicity (OIPN) is the most troublesome and dose-limiting side effect of oxaliplatin. There is …
Neuroprotective effects of monosialotetrahexosylganglioside
网页Monosialotetrahexosylganglioside (GM1) is a type of glycosphingolipid containing sialic acid that is closely related to cell-cell recognition, adhesion and signal conduction. GM1 is mainly composed of ceramide and oligosaccharide chains, and it is the only ganglioside that can permeate the blood-brain barrier.
Monosialotetrahexosylganglioside in the treatment of chronic ...
网页2021年10月29日 · We conducted a randomised controlled trial to investigate the efficacy of monosialotetrahexosylganglioside (GM1) in treating chronic OIPN.
Clinical Characteristics of Intravenous Injection of ...
网页2019年3月15日 · GBS primarily damages the spinal nerve root and peripheral nerves, but can also affect the cranial nerves and cause acute demyelination. This study analyzed the clinical features of intravenous injection of monosialotetrahexosyl ganglioside sodium-related Guillain-Barre syndrome (GRD-GBS).
Monosialotetrahexosylganglioside in the treatment of chronic ...
网页2021年10月29日 · Abstract. Background. Chronic oxaliplatin-induced peripheral neurotoxicity (OIPN) is the most troublesome and dose-limiting side effect of oxaliplatin. There is no effective treatment for chronic OIPN. We conducted a randomised controlled trial to investigate the efficacy of monosialotetrahexosylganglioside (GM1) in treating chronic OIPN. Methods.
Protective effects of monosialotetrahexosylganglioside sodium on H
网页2015年6月30日 · Monosialotetrahexosylganglioside sodium (GM1) is widely used in the treatment of central and peripheral neurological injuries. In addition to its neuroprotective activity, GM1 exerts protective effects on brain microvascular endothelial cells, although the mechanisms underlying these effects remain unclear. The aim of the present study was to ...
网页This study analyzed the clinical features of intravenous injection of monosialotetrahexosyl ganglioside sodium-related Guillain-Barre syndrome (GRD-GBS).
Clinical Characteristics of Intravenous Injection of ...
网页2019年3月1日 · This study analyzed the clinical features of intravenous injection of monosialotetrahexosyl ganglioside sodium-related Guillain-Barre syndrome (GRD-GBS).
- 某些结果已被删除